Lumilis, Luisa L.

HRN: 24-79-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2024
CEFUROXIME 1.5GM (VIAL)
04/09/2024
04/09/2024
IV
1.5g
Now
Thickly MSAF; For CS
Waiting Final Action 
04/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/09/2024
04/09/2024
IV
500mg
Now
Thickly MSAF, For CS
Waiting Final Action 
04/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/09/2024
04/15/2024
IV
500mg
Q8
Cs
Waiting Final Action 
04/09/2024
CEFUROXIME 1.5GM (VIAL)
04/09/2024
04/13/2024
IV
1.5g
Q8
Cs
Waiting Final Action 
04/10/2024
CEFUROXIME 500MG (TAB)
04/10/2024
04/16/2024
PO
500mg
BID
S/P CS
Waiting Final Action 
04/10/2024
METRONIDAZOLE 500MG (TAB)
04/10/2024
04/16/2024
PO
500mg
TID
S/P CS; Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: